Learn more about our CIDG team!
13 July 2018
Visiting Fellow Report: Monica Shah
12 July 2018
Ribavirin for treating Crimean Congo haemorrhagic fever
Published: 06 June 2018
Vaccines for preventing typhoid fever
Published: 31 May 2018
Smectite for acute infectious diarrhoea in children
Published: 25 April 2018
Ivermectin and permethrin for treating scabies
Published: 02 April 2018
Mefloquine for preventing malaria in pregnant women
Published: 28 March 2018
Since 1994, the Cochrane Infectious Diseases Group (CIDG) has been preparing systematic reviews on the benefits and harms of healthcare interventions for infectious diseases, in particular malaria, tuberculosis, diarrhoea, and tropical diseases. The CIDG editorial base is located at the Liverpool School of Tropical Medicine in Liverpool, UK. The CIDG is part of the EHCRC. The EHCRC, which is funded by UK aid from the UK Government for the benefit of developing countries, is the main funder of the CIDG.